Yucheng Sheng

7PUBLICATIONS
8CO-AUTHORS
Epidemiological modellingPharmacogenomicsPredictive and prognostic markersBasic pharmacologyPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 26, 2026
Model-Informed Dosing Regimen of Sugemalimab for European Patients With Non-Small Cell Lung Cancer: Bridging From Asian Clinical Data.

Yucheng Sheng, Zenglian Yue, Fengyan Xu

|Oct 10, 2024
Comprehensive population pharmacokinetic modelling of sugemalimab, an anti-programmed death-ligand 1 (PD-L1) human monoclonal antibody, in patients with solid tumours or lymphomas across multiple Phase I-III studies.

Kun Wang, Chaohsuan Pan, Fengyan Xu

|Dec 19, 2023
Tumor growth inhibition-overall survival modeling in non-small cell lung cancer: A case study from GEMSTONE-302.

Yucheng Sheng, Shu-Wen Teng, Jingru Wang

|Aug 02, 2023
Can a propensity score matching method be applied to assessing efficacy from single-arm proof-of-concept trials in oncology?

Shu-Wen Teng, Yu-Cheng Su, Ravikumar Pallantla

|Dec 29, 2022
Optimising intravenous salbutamol in children: a phase 2 study.

Sandra Walsh, Shan Pan, Yucheng Sheng

|Feb 26, 2022
Evaluating the Taste Masking Ability of Two Novel Dispersible Tablet Platforms Containing Zinc Sulfate and Paracetamol Reconstituted in a Breast Milk Substitute.

Samuel Orubu, Richard A Kendall, Yucheng Sheng

Pageof 2

Frequent Collaborators

2 joint publications

Shu-Wen Teng

2 joint publications

Kun Wang

2 joint publications

Fengyan Xu

1 joint publications

Catherine Tuleu